ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...
SANTA CLARA, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc., a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified ...
In a deal that might as well be termed a heart-to-heart, Shockwave Medical has made a bid to combine Neovasc’s cardiac device business with its own. Shockwave has offered up $27.25 in upfront cash for ...
Shockwave Medical specializes in developing and commercializing medical devices using IVL technology for treating calcified plaque in vascular and heart valve diseases. The company has achieved ...
FREDERICK, MD, UNITED STATES, February 3, 2026 /EINPresswire.com/ — Limitless Evolution announces the launch of the ReGen Medical RCT Shockwave Device, an advanced ...
The FDA on Dec. 28 permitted the marketing of Sanuwave’s Dermapace System to treat adults with diabetic foot ulcers. Here are three things to know. 1. The Dermapace System is an external shock wave ...
As an adjunct to bypass surgery for ischemic cardiomyopathy, a cardiac shockwave therapy aimed at regenerating ischemic myocardium boosted left ventricular ejection fraction (LVEF) and physical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results